Stimulant Oxytocin Study
NCT03016598
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
42
Enrollment
FED
Sponsor class
Conditions
Stimulant Use & Co-occuring Opioid Use Disorders
Interventions
DRUG:
Intranasal oxytocin
DRUG:
Intranasal placebo
Sponsor
VA Office of Research and Development